SEED logo

Origin Agritech Limited (SEED) News & Sentiment

Origin Agritech Limited (SEED) Q4 2024 Earnings Call Transcript
Origin Agritech Limited (SEED) Q4 2024 Earnings Call Transcript
Origin Agritech Limited (SEED) Q4 2024 Earnings Call Transcript
SEED
seekingalpha.comFebruary 11, 2025

Origin Agritech Limited (NASDAQ:SEED ) Q4 2024 Earnings Conference Call February 11, 2025 8:00 AM ET Company Participants Matthew Abenante - Strategic Investor Relations Weibin Yan - Chief Executive Officer Patrick Cheng - Chief Financial Officer Conference Call Participants Operator Thank you for standing by, and welcome to the Origin Agritech Fiscal Year 2024 Conference Call. Please note that, today's call is being recorded.

Origin Agritech Reports 24.6% Revenue Growth and Key Technological Milestones in Fiscal Year 2024
Origin Agritech Reports 24.6% Revenue Growth and Key Technological Milestones in Fiscal Year 2024
Origin Agritech Reports 24.6% Revenue Growth and Key Technological Milestones in Fiscal Year 2024
SEED
prnewswire.comFebruary 10, 2025

Announces Filing of Annual Report on Form 20-F for Fiscal Year 2024 BEIJING , Feb. 10, 2025 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced financial results for the year ended September 30, 2024.

SEED Receives FDA Rare Pediatric Disease and Orphan Drug Designations for Lead Oncology Asset RBM39 Degrader and Enters Strategic Transactions with New Investors
SEED Receives FDA Rare Pediatric Disease and Orphan Drug Designations for Lead Oncology Asset RBM39 Degrader and Enters Strategic Transactions with New Investors
SEED Receives FDA Rare Pediatric Disease and Orphan Drug Designations for Lead Oncology Asset RBM39 Degrader and Enters Strategic Transactions with New Investors
SEED
globenewswire.comJanuary 28, 2025

KING OF PRUSSIA, Pa., Jan. 28, 2025 (GLOBE NEWSWIRE) -- SEED Therapeutics Inc. (“SEED”), a biotechnology company pioneering the discovery of molecular glues for targeted protein degradation (TPD) using its proprietary RITE3™ platform, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease and Orphan Drug designations to SEED's ST-01156 molecular glue. This novel agent degrades RBM39, an RNA splicing factor implicated in multiple mechanism-targeted solid tumor indications.

Origin Agritech Held Transgenic Breeding Seminar and Announces Partnerships with 12 Leading Agricultural Companies
Origin Agritech Held Transgenic Breeding Seminar and Announces Partnerships with 12 Leading Agricultural Companies
Origin Agritech Held Transgenic Breeding Seminar and Announces Partnerships with 12 Leading Agricultural Companies
SEED
prnewswire.comJanuary 17, 2025

BEIJING , Jan. 17, 2025 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced the signing of cooperation agreements (the "agreements") with 12 prominent agricultural companies, including Beidahuang Kenfeng Seed Co., Ltd.

Origin Agritech Holds Successful 2025 R&D and Business Management Conference
Origin Agritech Holds Successful 2025 R&D and Business Management Conference
Origin Agritech Holds Successful 2025 R&D and Business Management Conference
SEED
prnewswire.comDecember 17, 2024

BEIJING , Dec. 17, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, recently held its 2025 R&D and Business Management Conference in Beijing.

Origin Agritech Establishes Biotechnology Service Consortium to Accelerate Licensing and Commercialization of GMO and Gene Editing Technologies
Origin Agritech Establishes Biotechnology Service Consortium to Accelerate Licensing and Commercialization of GMO and Gene Editing Technologies
Origin Agritech Establishes Biotechnology Service Consortium to Accelerate Licensing and Commercialization of GMO and Gene Editing Technologies
SEED
prnewswire.comOctober 21, 2024

BEIJING , Oct. 21, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, is pleased to announce the establishment of the "Origin Marker Biological Breeding Service Consortium" in partnership with China Golden Marker Biotechnology Co., Ltd.

Origin Agritech Appoints Mr. Weibin Yan as Chief Executive Officer and Member of the Board of Directors; Dr. Gengchen Han to Remain as Chairman of the Board
Origin Agritech Appoints Mr. Weibin Yan as Chief Executive Officer and Member of the Board of Directors; Dr. Gengchen Han to Remain as Chairman of the Board
Origin Agritech Appoints Mr. Weibin Yan as Chief Executive Officer and Member of the Board of Directors; Dr. Gengchen Han to Remain as Chairman of the Board
SEED
prnewswire.comAugust 23, 2024

BEIJING , Aug. 23, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, is pleased to announce the appointment of Mr.

SEED Therapeutics (SEED) Enters into Strategic Research Collaboration with Eisai Co., Ltd. to Discover and Develop Novel Molecular Glue Degraders for Neurodegeneration and Oncology Indications
SEED Therapeutics (SEED) Enters into Strategic Research Collaboration with Eisai Co., Ltd. to Discover and Develop Novel Molecular Glue Degraders for Neurodegeneration and Oncology Indications
SEED Therapeutics (SEED) Enters into Strategic Research Collaboration with Eisai Co., Ltd. to Discover and Develop Novel Molecular Glue Degraders for Neurodegeneration and Oncology Indications
SEED
globenewswire.comAugust 6, 2024

SEED Concurrently Enters into Share Purchase Agreements for its Series A-3 Financing Led by Eisai SEED Concurrently Enters into Share Purchase Agreements for its Series A-3 Financing Led by Eisai

Origin Agritech Announces Long-Term Revenue Projections Across Key Product Lines Through 2029
Origin Agritech Announces Long-Term Revenue Projections Across Key Product Lines Through 2029
Origin Agritech Announces Long-Term Revenue Projections Across Key Product Lines Through 2029
SEED
prnewswire.comJuly 23, 2024

BEIJING , July 23, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, is pleased to announce its revenue projections for key product lines through the year 2029.

Origin Agritech Chairman and CEO Dr. Gengchen Han Provides Business Updates and Answers Questions from Investors
Origin Agritech Chairman and CEO Dr. Gengchen Han Provides Business Updates and Answers Questions from Investors
Origin Agritech Chairman and CEO Dr. Gengchen Han Provides Business Updates and Answers Questions from Investors
SEED
prnewswire.comJuly 11, 2024

BEIJING, July 11, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, provided a business update from Dr. Gengchen Han, Chairman and CEO of Origin Agritech.

  • 1(current)
  • 2
  • 1(current)
  • 2